tiprankstipranks
Trending News
More News >
Mangalam Drugs & Organics Ltd. (IN:MANGALAM)
:MANGALAM
India Market

Mangalam Drugs & Organics Ltd. (MANGALAM) Income Statement

Compare
0 Followers

Mangalam Drugs & Organics Ltd. Income Statement

Last quarter (Q4 2025), Mangalam Drugs & Organics Ltd.'s total revenue was ₹727.77M, a decrease of -28.81% from the same quarter last year. In Q4, Mangalam Drugs & Organics Ltd.'s net income was ₹594.00K. See Mangalam Drugs & Organics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 3.18B₹ 3.67B₹ 3.70B₹ 4.47B₹ 3.80B
Gross Profit
₹ 1.50B₹ 188.12M₹ 287.77M₹ 546.89M₹ 976.69M
Operating Expenses
₹ 1.31B₹ 162.23M₹ 392.84M₹ 599.78M₹ 532.22M
Depreciation and Amortization
₹ 166.07M₹ 146.51M₹ 109.89M₹ 102.49M₹ 91.75M
EBITDA
₹ 358.23M₹ 139.86M₹ 259.54M₹ 451.84M₹ 550.15M
Operating Income
₹ 192.16M₹ 10.47M₹ 149.65M₹ 388.05M₹ 444.47M
Other Income/Expenses
₹ -144.30M₹ -121.20M₹ -127.51M₹ -110.72M₹ -49.28M
Pretax Income
₹ 47.86M₹ -110.73M₹ 22.14M₹ 277.33M₹ 395.19M
Net Income
₹ 67.21M₹ -90.72M₹ 12.70M₹ 196.57M₹ 279.71M
Per Share Metrics
Basic EPS
₹ 4.25₹ -5.73₹ 0.80₹ 12.42₹ 17.67
Diluted EPS
₹ 4.25₹ -5.73₹ 0.80₹ 12.42₹ 17.67
Weighted Average Shares Outstanding
15.81M 15.83M 15.83M 15.83M 15.83M
Weighted Average Shares Outstanding (Diluted)
15.81M 15.83M 15.83M 15.83M 15.83M
Currency in INR

Mangalam Drugs & Organics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis